SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
VALEANT PHARMACEUTICALS INTERNATIONAL IN
(NYSE:VRX Last Sale: 99.57 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NYSE: (VRX : $99.57)
$29,393 million Market Cap at September 12, 2013
Employs 1,500.
Drugs SubIndustry up .00% / Health Industry up .00% Today
7150 Mississauga Road Research Report Earnings Snapshot - Last 10/20/18
Mississauga, Ontario, L5N 8M5 Fact Sheet
Canada Financial Statements
Phone: (905) 286-3000 Peer Comparison
Annual Reports

J. Michael Pearson, CEO, Rajiv De Silva, COO, Margaret Mulligan, CFO
Canada's largest drug maker. Focus is the clinical evaluation, formulation, and manufacture of advanced drug delivery products. Formerly BIOVAIL CORP until October 4, 2010 merger with (old) VALEANT PHARMACEUTICALS INTERNATIONAL (N:VRX) June 21, 2010, when adopted VRX management and name, and issued 135 million new shares. BVF holders own 50.5% of the combined companies. VRX holders received 1.7809 BVF and $16.77 cash per VRX. SEC fraud charges settled with $10 million payment March 25, 2008. Acquired FUISZ TECHNOLOGIES LTD (Nasdaq:FUSE) in two step agreement. Step one, completed August 27, 1999, was a cash tender offer of $7 per share to bring BVF's ownership to 49%. Step two was a stock for stock exchange November 12, 1999 for 2.6 million shares, issuing 0.1197 BVF per FUSE. August 2, 2006, unfavorable ruling granted summary judgment to Anchen Pharmaceutical Inc. on the patent for depression drug Wellbutrin XL, allowing Anchen to make a generic version of the drug. Acquired Bausch & Lomb from Warburg Pincus for $8.7 billion May 28, 2013.
Historical Charts    Technical Analysis
No Historical Data available for VRX

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common VRX $99.57 $ 0 $99.31 $100.82 610,388 $52.5 $105.4 295,200
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock $29,393,064
Dividend Information
Annual Dividend Yield Earnings Payout

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
28-SEP-10 BVF Symbol Changed to VRX
13-OCT-00 BVF Split 2 for 1
19-JAN-00 BVF Split 2 for 1

A580
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex